Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gu Ben Hua Yu Formula is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of moderate to severe psoriasis. It is a complex mixture of herbal ingredients designed to be administered orally. In clinical research, specifically a Phase 1/2 pilot study (NCT04785027), the formula is being evaluated in combination with expanded allogeneic adipose-derived mesenchymal stem cells (AD-MSCs). The treatment regimen involves daily oral administration of the formula alongside periodic intravenous infusions of AD-MSCs, aiming to leverage potential synergistic effects on immune modulation and skin lesion improvement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gu Ben Hua Yu Formula.